Bloomberg – Ori Hershkovitz, head of pharmaceutical research at Sphera Funds Management Ltd., is leaving after seven years of stock-picking at Israel’s largest hedge fund.
Hershkovitz, who frequently spoke out against management decisions at Teva Pharmaceutical Industries Ltd. (TEVA), declined to discuss the reasons for his departure when contacted by Bloomberg by telephone. He will be replaced by David Munno, who is shifting from Wexford Capital Fund, Tel Aviv-based Sphera said in a statement.
